Cochlear

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Cochlear sits in the top decile of US sponsors by registered trial count (#484 of 15,742 sponsors by registered trial count).

34 total trials 4 currently recruiting 24 completed top decile by trial count

Cochlear: 34 sponsored US clinical trials, 4 recruiting.

Cochlear sponsors 34 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 24 completed. The most-studied condition in this pipeline is Sensorineural Hearing Loss, with 5 trials.

Top-decile sponsor footprint

Cochlear ranks in the top decile of sponsors by registered trial count (#484 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 62/100

24 of 27 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

34 total, page 1 of 1

RECRUITING NA

A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

NCT07287124

RECRUITING

Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array

NCT06936449

RECRUITING NA

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App

NCT06098482

RECRUITING NA

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

NCT05318417

ACTIVE NOT RECRUITING NA

Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

NCT06598059

ACTIVE NOT RECRUITING NA

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

NCT06293482

NOT YET RECRUITING NA

Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients

NCT07582198

COMPLETED NA

Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant Participants

NCT07077070

COMPLETED NA

Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients

NCT07156461

COMPLETED NA

A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation and Sound Coding in Adults.

NCT05641155

COMPLETED NA

Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation

NCT05709223

COMPLETED NA

Osia 2 Pediatric Expansion Study

NCT05000931

COMPLETED NA

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

NCT04741009

COMPLETED NA

Cochlear Implant With Dexamethasone Eluting Electrode Array

NCT04750642

COMPLETED NA

Osia CPT Code Study

NCT04320407

TERMINATED NA

Hearing Loss in Older Adults Study

NCT03382769

TERMINATED NA

An Evidence Based Delivery Model of Care for Newly Implanted Adult CI Recipients

NCT03904420

COMPLETED NA

Evaluation of the Baha SoundArc in Pediatric Patients

NCT03333577

COMPLETED NA

Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population

NCT03304106

COMPLETED NA

Clinical Performance of a New Implant System for Bone Conduction Hearing

NCT03086135

COMPLETED NA

Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults

NCT03007472

TERMINATED NA

Implantation With the Nucleus CI532 Cochlear Implant in Adults

NCT02677220

COMPLETED NA

CI532 - Early Experience Study

NCT02755935

COMPLETED NA

Usability of the CP950 Sound Processor

NCT02727842

COMPLETED

Implantation of the Cochlear™ Nucleus® Hybrid S Round Window (S-RW) in Adults

NCT02638883

COMPLETED NA

Safety and Efficacy of Remote Programming of Nucleus Cochlear Implants

NCT02644343

COMPLETED

Fundamental Asynchronous Stimulus Timing Sound Coding Study

NCT02698787

COMPLETED NA

Hybrid L24 New Enrollment Post Approval Study

NCT02379819

COMPLETED NA

N6 Input Processing in Traditional CI Recipients

NCT02239263

COMPLETED NA

Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults

NCT01867008

COMPLETED NA

Implantation of the Cochlear® Nucleus® System in Adults With Single-Sided Deafness

NCT01670006

COMPLETED NA

Evaluation of a Revised Indication for Determining Adult Cochlear Implant Candidacy

NCT01337076

COMPLETED NA

Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System

NCT01072409

COMPLETED NA

Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System

NCT00678899

What is open in the Cochlear pipeline

4 recruiting of 34 indexed (12% open); 24 completed (71%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Sensorineural Hearing Loss (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Cochlear: open-pipeline peers nationwide

Peers matched on 34 registered trials and 12% open enrollment, not the therapeutic-area sidebar.

Cochlear sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1520253035 0%10%20%30%40%50% Total trials Recruiting share CochlearAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)American RegentAmicus TherapeuticsEmergent BioSolutionsErchonia CorporationHutchmedInternational Maternal Pediatric Adolescent AIDS Clinical Trials GroupPrECOG
Cochlear sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cochlear sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 34 trials (± recruiting share)

Sponsors near 12% open enrollment (± trial volume)

What to do with this Cochlear page

34 registered trials is a research-attention snapshot, not an endorsement of Cochlear or any single study.

  • 4 of Cochlear's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Sensorineural Hearing Loss is the condition Cochlear studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sensorineural Hearing Loss trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cochlear pipeline card: 34 registered trials from official public datasets.Report a data error.